This site limits showing results to the last 12 months. For full access, subscribe at CustomerGauge.com

NPS Intelligence (beta)

Disclosed NPS & retention by vertical

Pharmaceuticals

4
Companies
with a public disclosure
1
Gave a number
a disclosed NPS
—
Median latest NPS
last 3 years
23
Silent
known companies, nothing published

Lighthouse companies

Piramal Pharma Solutions
Pharmaceuticals · piramal.com
55NPS · 2025
“Piramal Pharma Solutions achieved a Net Promoter Score of 55, exceeding industry averages in a third-party assessment by DNV.”
— reported by prnewswire.com · 15 Dec 2025
Latest: prnewswire.com

More companies

Number of entries in brackets.

Silent

Companies we know of in pharmaceuticals that have published nothing on NPS or retention.

Fortune 500 #65
Fortune 500 #69
Fortune 500 #142
Fortune 500 #297
Pharmaceutical Company
Pharmaceutical Company
Pharmaceutical Company
Pharmaceutical
Pharmaceuticals
Life Sciences Reagents
Pharmaceutical Developer
Specialty Pharmaceutical
Pharmaceutical & OTC
Pharmaceutical Services
Specialty Pharmaceutical
Pharmaceutical Company
Pharmaceutical Developer

About these figures

Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.

NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.